Abstract
Several studies have shown the existence of an association between celiac disease (CD) and non-Hodgkin's lymphoma (NHL). Our aim was to evaluate the usefulness of the serum anti-tissue transglutaminase (anti-tTG) antibody assay in screening for CD in consecutive NHL patients. In all, 80 consecutive patients (median age 61 years) with a new diagnosis of NHL were included. To compare the frequency of CD and of positive results for the anti-tTG assay, we enrolled 500 blood donors. In all patients serum anti-tTG was determined with two different ELISA: one based on tTG from guinea pig (gp-tTG) and the other based on human recombinant t-TG (h-tTG) as the antigens. Serum anti-endomysial antibodies (EmA) were also assayed. Subjects with positive serum EmA and/or anti-tTG underwent intestinal biopsy for histology study, HLA-DQ phenotype determination, and serum anti-gliadin (AGA) assay. Eight of 80 (10%) NHL patients were positive for anti-tTG ELISA—two of these exclusively for anti-gp-tTG and six for anti-h-tTG (7.5%). None of the 80 NHL patients were positive for serum EmA. The frequency of anti-tTG positivity in the blood donor controls was 2/500 (0.4%), significantly lower than that observed in the NHL patients (P < 0.0001). Both these blood donors were found to have CD. Only in one anti-h-tTG-positive NHL patient was there intestinal mucosa atrophy, and follow-up confirmed a CD diagnosis (CD frequency in NHL patients is 1.2%; versus blood donors: P = 0.4). In all the other seven anti-tTG-positive NHL patients a normal intestinal architecture was found, although, inflammatory infiltration of the lamina propria was observed in four patients. No anti-tTG-positive NHL patients, including the subject diagnosed as having CD, had a family history of CD, and all had normal weight and no signs of malabsorption. Anti-tTG false positive results were associated with a higher frequency of serum autoantibody positivity and T-cell type NHL. In conclusion, NHL patients the anti-tTG assay often gives discordant data with the EmA assay, with a high frequency of anti-tTG false positive results for CD diagnosis.
Similar content being viewed by others
REFERENCES
Holmes GHT, Stokes PL, Sorahan TM, Prior P, Waterhouse JAH, Cooke WT: Coeliac disease, gluten-free diet and malignancy. Gut17:612–619, 1976
Holmes GHT, Prior P, Lane MR, Pope D, Allan RN: Malignancy in coeliac disease-effect of a gluten-free diet. Gut 30:333–338,1989
Corrao G, Corazza GR, Bagnardi V, Brusco G, Ciacci C, Cottone M, Guidetti CS, Usai P, Cesari P, Pelli MA, Loperfido S, Volta U, Calabro A, Certo M, Club del Tenue Study Group: Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 358:356–361, 2001
Cottone M, Termini A, Oliva L, Magliocco A, Marrone C, Orlando A, Pinzone F, Di Mitri R, Rosselli M, Rizzo A, Pagliaro L: Mortality and causes of death in celiac disease in a Mediterranean area. Dig Dis Sci 44:2538–2541, 1999
Swinson CM, Slavin G, Coles EC, Booth CC: Celiac disease and malignancy. Lancet 1:111–115, 1983
Gale J, Simmonds PO, Mead GM, Sweetenham JW, Wright DH: Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol 18:795–803, 2000
Catassi C, Ratsch AM, Fabiani E, Rossini M, Bordicchia F, Candela F, Coppa GV, Giorgi PC: Celiac disease in the year 2000: exploring the iceberg. Lancet 343:200–203, 1994
Not T, Horvath K, Hill ID, Partanen J, Hammed A, Maggazzù G, Fasano A: Celiac disease risk in the USA: high prevalence of anti-endomysium antibodies in healthy blood donors. Scand J Gastroenterol 33:494–498, 1998
Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D: Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Med 3:797–801, 1997
Dietrich W, Laag E, Schooper H, Volta U, Ferguson A, Gillet H, et al: Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 115(6): 1317–1321, 1998
Sulkanen S, Halttunen T, Laurila K, Kolho K, Korponay-Szabo I, Sarnesto A, et al: Tisue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting coeliac disease. Gastroenterology 115:1322–1328, 1998
Harris NL, Jaffe ES, Stein H: A revised European-American classification of lymphoid neoplasm: a proposal from the international Lymphoma Study Group. Blood 84:1361–1392, 1994
Hiddemann W, Longo DL, Coiffier B, Fisher RI, Cabanillas F, Cavalli F, Nadler LM, De Vita VT, Lister TA, Armitage JO: Lymphoma classification-the gap between biology and clinical management is closing. Blood 88:4085–4089, 1996
Troncone R, Maurano F, Rossi M, Micillo M, Greco L, Auricchio R et al.: IgA antibodies to tissue transglutaminase: an effective diagnostic test for celiac disease. J Pediatr 134:166–171, 1999
Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK: Revised criteria for the diagnosis of coeliac disease. Arch Dis Child 65:909–911, 1990
Carroccio A, Vitale G, Di Prima L, Chifari N, Napoli S, La Russa C, Gulotta G, Averna MR, Montalto G, Mansueto S, Notarbartolo A.: Anti-transglutaminase ELISAs and anti-endomysial assay compared in the diagnosis of coeliac disease. A prospective study. Clin Chem 48(9): 1546–1550, 2002
Carroccio A, Cavataio F, Iacono G, Agate V, Ippolito S, Kazmierska I, Campagna P, Soresi M, Montalto G: IgA antiendomysial antibodies on the umbilical cord in diagnosing celiac disease. Scand J Gastroenterol 31:759–763, 1996
Carroccio A, Iacono G, Montalto G, Cavataio F, Soresi M, Kazmierska I, Notarbartolo A: Immunological and absorptive tests in celiac disease: can they replace intestinal biopsies? Scand J Gastroenterol28:673–676, 1993
Picarelli A, Maiuri L, Mazzilli MC, Coletta S, Ferrante P, Di Giovambattista F, Greco M, Torsoli A, Auricchio S: Gluten-sensitive disease with mild enteropathy. Gastroenterology 111:608–616, 1996
Olerup O, Aldener A, Fogdell A: HLA-DQB1 and-DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 41:119–134, 1993
Catassi C, Fabiani E, Corrao G, Barbato M, De Renzo A, Carella A et al.: Risk of non-Hodgkin lymphoma in celiac disease. JAMA287:1413–1419, 2002
Farrell RJ, Kelly CP: Celiac sprue. N Engl J Med 346:180–188,2002
Sblattero D, Berti I, Trevisiol C, Marzari R, Tommasini A, Bradbury A et al.: Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for coeliac disease. Am J Gastroenterol 95:1253–1257, 2000
Sulkanenen S, Halttunen T, Marttinen A, Leivo EL, Laurila K, Maki M: Autoantibodies in celiac disease: importance of fibroblasts. J Pediatr Gastroenterol Nutr 27:206–213, 1998
Carroccio A, Fabiani E, Iannitto E, Giannitrapani L, Gravina F, Montalto G, Catassi C: Tissue transglutaminase auto-antibodies in patients with non-Hodgkin's lymphoma and without celiac disease: case reports. Digestion 62:271–275, 2000
Carroccio A, Giannitrapani L, Soresi M, Not T, Iacono G, Di Rosa C, Panfili E, Notarbartolo A, Montalto G: Guinea pig transglutaminase immuno-linked assay does not predict celiac disease in patients with chronic liver disease. Gut 49:506–511, 2001
Clemente MG, Frau F, Musu MP, De Virgilis S: Antibodies to tissue transglutaminase outside coeliac disease. Ital J Gastroenterol Hepatol 6:546, 1999
Kourtis AP, Boussiotis VA, Lymberi P, Pangalis GA: Increased natural antibodies activity in sera of patients with malignant non-Hodgkin lymphomas containing paraproteins. Am J Hematol 46:283–288, 1994
Polliack A, Lugassy G: Autoimmunity and autoimmune syndromes associated with and preceding the development of lymphoproliferative disorders. Leukemia 6(S4):152–154, 1992
Marsh MN, Bjarnason I, Shaw J, Ellis A, Baker R, Peters TJ: Studies of intestinal lymphoid tissue. XIV-HLA status, mucosal morphology, permeability and epithelial lymphocyte populations in first degree relatives of patients with celiac disease. Gut 31:32–33, 1990
Maki M, Holm K, Collin P, Savilahti E: Increase in °=± T cell receptor bearing lymphocytes in normal small bowel mucosa in latent coeliac disease. Gut 32:1412–1414, 1991
Iltanen S, Holm K, Partanen J, Laippala P, maki M: Increased density of jejunal °=± T cells in patients having normal mucosa. Marker of operative autoimmune mechanisms? Autoimmunity 29:179–187, 1999
Mathus-Vliegen EMH, Van Halteren H, Tytgat GNJ: Malignant lymphoma in coeliac disease: various manifestations with distinct symptomatology and prognosis? J Intern Med 236:43–49, 1994
Korponay-Szabò IR, Sulkanen S, Halttunen T, Maurano F, Rossi M, Mazzarella G, et al: Tissue transglutaminase is the target in both rodent and primate tissues for celiac disease-specific autoantibodies. J Pediatr Gastroenterol Nutr 31:520–527, 2000
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carroccio, A., Iannitto, E., Di Prima, L. et al. Screening for Celiac Disease in Non-Hodgkin's Lymphoma Patients: A Serum Anti-Transglutaminase–Based Approach. Dig Dis Sci 48, 1530–1536 (2003). https://doi.org/10.1023/A:1024811707311
Issue Date:
DOI: https://doi.org/10.1023/A:1024811707311